1-4 of 4
Ute Friedrich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Severe Hemophilia a without Inhibitors: Results from the Phase 2 explorer5 Trial

Hermann Eichler, Pantep Angchaisuksiri, MD, Jan Astermark, MD PhD, Gary Benson, Katarina Cepo, Pratima Chowdary, MD, Ute Friedrich, PhD, Kaan Kavakli, Allison P Wheeler, MD, Johannes Oldenburg, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2417.
https://doi.org/10.1182/blood-2019-122300
Published: 2019
Journal Articles

Concizumab (Anti-TFPI) Exposure-Response Modeling in Patients with Hemophilia A

Hermann Eichler, MD, Pantep Angchaisuksiri, MD, Kaan Kavakli, MD, Paul Knöbl, MD PhD, Jerzy Windyga, Victor Jimenez-Yuste, Ute Friedrich, PhD, Philip Delff Andersen, Pratima Chowdary
Journal: Blood
Blood (2017) 130 (Supplement 1): 3672.
https://doi.org/10.1182/blood.V130.Suppl_1.3672.3672
Published: 2017
Journal Articles

Secondary Prophylaxis with rFVIIa Improves Quality of Life of Hemophilia Patients with Inhibitors and Frequent Bleeds.

Barbara A. Konkle, Liselotte S. Ebbesen, Guenter K.H. Auerswald, Ute Friedrich, Rolf C.R. Ljung, Harold R. Roberts, W. Keith Hoots
Journal: Blood
Blood (2006) 108 (11): 1028.
https://doi.org/10.1182/blood.V108.11.1028.1028
Published: 2006
Journal Articles

Randomized, Prospective Clinical Trial of rFVIIa for Secondary Prophylaxis in Hemophilia Patients with Inhibitors.

Barbara A. Konkle, Liselotte S. Ebbesen, Ute Friedrich, Raul P. Bianco, Toshko Lissitchkov, Luminita Rusen, Margit A. Serban
Journal: Blood
Blood (2006) 108 (11): 766.
https://doi.org/10.1182/blood.V108.11.766.766
Published: 2006